Gilead Sciences reported $2.82B in Stock for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Agios Pharmaceuticals AGIO:US USD 8.49M 3.32M
Alnylam Pharmaceuticals ALNY:US USD 128.96M 13.47M
Amgen AMGN:US USD 4.93B 173M
Biogen BIIB:US USD 1.34B 30.6M
Biomarin Pharmaceutical BMRN:US USD 894.08M 54.62M
Coherus Biosciences CHRS:US USD 38.79M 11.07M
Gilead Sciences GILD:US USD 2.82B 218M
GlaxoSmithKline GSK:LN GBP 5.15B 487M
Intercept Pharmaceuticals ICPT:US USD 6.46M 188K
Moderna Inc MRNA:US USD 949M 1.13B
Novartis NOVN:VX USD 7.18B 396M
Ptc Therapeutics PTCT:US USD 21.81M 7M
Puma Biotechnology PBYI:US USD 4.53M 926K
Regeneron Pharmaceuticals REGN:US USD 2.4B 10.3M
Sarepta Therapeutics SRPT:US USD 203.97M 17.22M
Teva Pharmaceutical Industries TEVA:US USD 3.83B 26M
United Therapeutics UTHR:US USD 102M 11M
Vertex Pharmaceuticals VRTX:US USD 460.6M 72.4M
YTE INCY:US USD 120.96M 75.09M